Omega Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Omega Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 49% to $3,094,000. The net income raised on -$97,428,000 and profit margin reached -3149%. Total operating expenses were $103,355,000.
Profit Margin
| 2019 | 0 | -18.52M | |
|---|---|---|---|
| 2020 | 0 | -30.19M | |
| 2021 | 144K | -69.16M | -48029.17% |
| 2022 | 2.07M | -102.63M | -4951.09% |
| 2023 | 3.09M | -97.42M | -3148.93% |
OMGA Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 3.09M | 2.07M | 144K | 0 | 0 |
Cost of revenue | 65.86M | 5.19M | 1.38M | 1.14M | 794K |
Gross profit | -62.77M | -3.11M | -1.24M | -1.14M | -794K |
Operating exp. | |||||
Research and development | 77.16M | 79.99M | 47.86M | 21.06M | 11.93M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 103.35M | 104.83M | 66.17M | 28.64M | 17.33M |
Operating income | -100.26M | -102.76M | -66.03M | -28.64M | -17.33M |
Other income (expenses), net | 2.83M | 65K | -2.24M | -802K | -606K |
Income before tax | -97.42M | -102.70M | -68.28M | -29.44M | -17.94M |
Income tax expense | 0 | -65K | 882K | 752K | 584K |
Net income | -97.42M | -102.63M | -69.16M | -30.19M | -18.52M |
Earnings per share | |||||
Basic EPS | -1.8 | -2.14 | -1.45 | -0.63 | -0.39 |
Diluted EPS | -1.8 | -2.14 | -1.45 | -0.63 | -0.39 |
| Data source | Data source | Data source |